TEVA(TEVA) - 2025 Q4 - Earnings Call Transcript

Teva Pharmaceutical Industries (NYSE:TEVA) Q4 2025 Earnings call January 28, 2026 08:00 AM ET Company ParticipantsChris Schott - Managing DirectorChris Stevo - SVP of Investor RelationsEli Kalif - CFOEric Hughes - Head of R&D and CMOLes Sulewski - VPLouise Chen - Managing DirectorRichard Francis - CEOUmer Raffat - Senior Managing DirectorConference Call ParticipantsAsh Verma - Equity Research AnalystDavid Amsellem - Senior Research AnalystDennis Ding - SVP and Equity Research AnalystJason Gerberry - Managin ...